Heavy men fare poorly with prostate cancer

	Tweet

A high body mass index (BMI) does not increase the risk of developing prostate cancer, but once the disease occurs, a high BMI is associated with a greater risk of dying from the cancer, researchers report.

“This is a large study that shows a convincing dose-response association between obesity and adult weight gain and death from prostate cancer,” lead investigator Dr. Margaret E. Wright told Reuters Health.

Wright, at the National Cancer Institute, Bethesda, Maryland, and colleagues studied data on 287,760 men taking part in a diet and health study. After 5 years of follow-up, there were 9986 new cases of prostate cancer, and after 6 years of follow-up, there were 173 deaths from prostate cancer, the researchers report in the medical journal Cancer.

A BMI up to 25 is considered normal weight, up to 30 is classified as overweight, and 30 and up indicates obesity.

In this study, a higher BMI at the outset was associated with significantly reduced likelihood of developing prostate cancer. Men with a BMI of 40 or more had a 33 percent lower risk of prostate cancer than men with a BMI of less than 25.

Conversely, the risk of dying of prostate cancer rose significantly with increasing BMI. This amounted to a 25 percent greater risk for men with a BMI between 25 and 29.9, a 46 percent increase for BMIs between 30 and 34.9, and more than double the risk if BMI was 35 or more.

There was also a significant association between weight gain in adulthood and prostate cancer mortality.

“The growing prevalence of obesity in Western countries is alarming,” Wright said, “and reducing the risk of prostate cancer death is only one among many health reasons to maintain a healthy weight through diet and exercise.”

SOURCE: Cancer, February 15, 2007.

RELATED STORIES:
Acquisition of Robotic Technology Leads to Increased Rates of Prostate Cancer Surgery   Untreated prostate cancer no death sentence   Older men get less effective prostate cancer care   UAB Cancer Center, Urologists Affirm Men Should Take Lead in Deciding to Test for Prostate Cancer   Cancer in sister affects black men’s cancer risk   Young men with prostate cancer benefit from radiation therapy   Trio of studies support use of PET/CT scans as prostate cancer staging tool   Prostate Cancer Translational Research in Europe meeting: Search for biomarkers continues   Scientists Find Second Site for Prostate Cancer Gene   Clinicians Map Group at High Risk for Aggressive, ‘Hidden’ Prostate Cancer   Gene Fusion Discovery May Lead to Improved Prostate Cancer Test   Prostate cancer surgery more costly for obese men   Can Changing Your Lifestyle Help Treat Prostate Cancer?   Drug shows promise in prostate cancer spread to bone   Family history of prostate cancer does not affect some treatment outcomes   Change in PSA level does not predict prostate cancer   Obese men less likely to get biopsy after PSA screening   Gene variants in Japanese prostate cancer patients   New diagnostic tool for prostate cancer   Minimally invasive breakthrough for men’s enlarged prostates improves symptoms   Prostate cancer gene test provides new early detection   Genes may play role in risk assessment for prostate cancer among Hispanics and caucasians

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]